OR7E2P

Across TCGA pan-cancer cohorts, OR7E2P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated OR7E2P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OR7E2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E2P expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRP show a favorable association.

LUAD, LIHC, and BLCA are the cancer types where OR7E2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.388	0.590	<.001	111	view →
LIHC	OS	Tertile	All	0.369	0.729	<.001	60	view →
BLCA	OS	Tertile	All	0.649	0.360	.007	42	view →
THYM	OS	Tertile	All	0.563	0.912	.002	39	view →
UCEC	DFS	Tertile	III,IV	0.699	0.813	.011	36	view →
KIRP	OS	Quartile	III,IV	0.911	0.609	.006	32	view →
LGG	DFS	Median	All	0.737	0.866	<.001	30	view →
THCA	OS	Tertile	II,III,IV	0.321	0.970	.004	29	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	27	view →
UCS	DFS	Tertile	All	0.348	0.576	.032	24	view →
LAML	DFS	Tertile	All	0.259	0.552	.025	24	view →
KICH	OS	Median	All	1.000	0.867	.008	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

OR7E2P–LUAD (OS)

Open the LUAD breakdown →